vs
阿普塔集团（ATR）与利氏兄弟拍卖行（RBA）财务数据对比。点击上方公司名可切换其他公司
利氏兄弟拍卖行的季度营收约是阿普塔集团的1.2倍（$1.2B vs $962.7M），利氏兄弟拍卖行净利率更高（9.1% vs 7.7%，领先1.4%），阿普塔集团同比增速更快（13.5% vs 5.4%），利氏兄弟拍卖行自由现金流更多（$186.5M vs $96.9M），过去两年利氏兄弟拍卖行的营收复合增速更高（6.3% vs 2.6%）
阿普塔集团（AptarGroup, Inc.）是总部位于美国的全球性制造企业，主营消费品分配包装产品及药物给药装置的研发与生产，目前在全球18个国家设有生产运营基地，服务医药、快消等多领域客户。
利氏兄弟拍卖行（股票代码RBA）是全球知名的工业资产拍卖服务商，注册地位于加拿大，属公开上市企业，总部设在美国伊利诺伊州韦斯特切斯特，普通股同时在多伦多证券交易所与纽约证券交易所挂牌交易。
ATR vs RBA — 直观对比
营收规模更大
RBA
是对方的1.2倍
$962.7M
营收增速更快
ATR
高出8.1%
5.4%
净利率更高
RBA
高出1.4%
7.7%
自由现金流更多
RBA
多$89.6M
$96.9M
两年增速更快
RBA
近两年复合增速
2.6%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $962.7M | $1.2B |
| 净利润 | $74.3M | $109.7M |
| 毛利率 | — | — |
| 营业利润率 | 11.0% | 14.7% |
| 净利率 | 7.7% | 9.1% |
| 营收同比 | 13.5% | 5.4% |
| 净利润同比 | -26.4% | -7.4% |
| 每股收益（稀释后） | $1.13 | $0.53 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ATRRBA
| Q4 25 | $962.7M | $1.2B | ||
| Q3 25 | $961.1M | $1.1B | ||
| Q2 25 | $966.0M | $1.2B | ||
| Q1 25 | $887.3M | $1.1B | ||
| Q4 24 | $848.1M | $1.1B | ||
| Q3 24 | $909.3M | $981.8M | ||
| Q2 24 | $910.1M | $1.1B | ||
| Q1 24 | $915.4M | $1.1B |
净利润ATRRBA
| Q4 25 | $74.3M | $109.7M | ||
| Q3 25 | $127.9M | $95.5M | ||
| Q2 25 | $111.7M | $109.8M | ||
| Q1 25 | $78.8M | $113.4M | ||
| Q4 24 | $100.9M | $118.5M | ||
| Q3 24 | $100.0M | $76.1M | ||
| Q2 24 | $90.5M | $111.1M | ||
| Q1 24 | $83.1M | $107.4M |
营业利润率ATRRBA
| Q4 25 | 11.0% | 14.7% | ||
| Q3 25 | 14.2% | 14.5% | ||
| Q2 25 | 14.9% | 15.9% | ||
| Q1 25 | 12.8% | 17.1% | ||
| Q4 24 | 14.2% | 18.1% | ||
| Q3 24 | 15.2% | 15.6% | ||
| Q2 24 | 13.8% | 18.4% | ||
| Q1 24 | 12.2% | 18.7% |
净利率ATRRBA
| Q4 25 | 7.7% | 9.1% | ||
| Q3 25 | 13.3% | 8.7% | ||
| Q2 25 | 11.6% | 9.3% | ||
| Q1 25 | 8.9% | 10.2% | ||
| Q4 24 | 11.9% | 10.4% | ||
| Q3 24 | 11.0% | 7.8% | ||
| Q2 24 | 9.9% | 10.1% | ||
| Q1 24 | 9.1% | 10.1% |
每股收益（稀释后）ATRRBA
| Q4 25 | $1.13 | $0.53 | ||
| Q3 25 | $1.92 | $0.43 | ||
| Q2 25 | $1.67 | $0.53 | ||
| Q1 25 | $1.17 | $0.55 | ||
| Q4 24 | $1.48 | $0.58 | ||
| Q3 24 | $1.48 | $0.36 | ||
| Q2 24 | $1.34 | $0.54 | ||
| Q1 24 | $1.23 | $0.53 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $409.5M | $531.5M |
| 总债务越低越好 | $1.1B | $2.3B |
| 股东权益账面价值 | $2.7B | $5.6B |
| 总资产 | $5.3B | $12.1B |
| 负债/权益比越低杠杆越低 | 0.43× | 0.42× |
8季度趋势，按日历期对齐
现金及短期投资ATRRBA
| Q4 25 | $409.5M | $531.5M | ||
| Q3 25 | $264.8M | $674.7M | ||
| Q2 25 | $169.8M | $710.2M | ||
| Q1 25 | $136.8M | $578.1M | ||
| Q4 24 | $226.2M | $533.9M | ||
| Q3 24 | $327.9M | $650.7M | ||
| Q2 24 | $223.9M | $599.5M | ||
| Q1 24 | $201.1M | $462.8M |
总债务ATRRBA
| Q4 25 | $1.1B | $2.3B | ||
| Q3 25 | $546.0M | $2.6B | ||
| Q2 25 | $535.1M | $2.6B | ||
| Q1 25 | $561.2M | $2.6B | ||
| Q4 24 | $688.1M | $2.6B | ||
| Q3 24 | $822.7M | $2.7B | ||
| Q2 24 | $681.5M | $2.8B | ||
| Q1 24 | $680.4M | $2.9B |
股东权益ATRRBA
| Q4 25 | $2.7B | $5.6B | ||
| Q3 25 | $2.8B | $5.5B | ||
| Q2 25 | $2.7B | $5.5B | ||
| Q1 25 | $2.5B | $5.3B | ||
| Q4 24 | $2.5B | $5.2B | ||
| Q3 24 | $2.5B | $5.2B | ||
| Q2 24 | $2.4B | $5.2B | ||
| Q1 24 | $2.3B | $5.1B |
总资产ATRRBA
| Q4 25 | $5.3B | $12.1B | ||
| Q3 25 | $5.1B | $12.2B | ||
| Q2 25 | $4.9B | $12.2B | ||
| Q1 25 | $4.5B | $11.9B | ||
| Q4 24 | $4.4B | $11.8B | ||
| Q3 24 | $4.6B | $11.9B | ||
| Q2 24 | $4.5B | $12.1B | ||
| Q1 24 | $4.4B | $12.0B |
负债/权益比ATRRBA
| Q4 25 | 0.43× | 0.42× | ||
| Q3 25 | 0.20× | 0.47× | ||
| Q2 25 | 0.20× | 0.47× | ||
| Q1 25 | 0.22× | 0.50× | ||
| Q4 24 | 0.28× | 0.50× | ||
| Q3 24 | 0.32× | 0.52× | ||
| Q2 24 | 0.28× | 0.55× | ||
| Q1 24 | 0.29× | 0.58× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $183.7M | $255.2M |
| 自由现金流经营现金流 - 资本支出 | $96.9M | $186.5M |
| 自由现金流率自由现金流/营收 | 10.1% | 15.5% |
| 资本支出强度资本支出/营收 | 9.0% | 5.7% |
| 现金转化率经营现金流/净利润 | 2.47× | 2.33× |
| 过去12个月自由现金流最近4个季度 | $299.6M | $719.2M |
8季度趋势，按日历期对齐
经营现金流ATRRBA
| Q4 25 | $183.7M | $255.2M | ||
| Q3 25 | $177.6M | $239.7M | ||
| Q2 25 | $126.0M | $326.5M | ||
| Q1 25 | $82.7M | $156.8M | ||
| Q4 24 | $178.2M | $184.5M | ||
| Q3 24 | $229.3M | $285.4M | ||
| Q2 24 | $143.6M | $337.3M | ||
| Q1 24 | $92.3M | $124.8M |
自由现金流ATRRBA
| Q4 25 | $96.9M | $186.5M | ||
| Q3 25 | $114.3M | $188.5M | ||
| Q2 25 | $62.5M | $241.7M | ||
| Q1 25 | $25.9M | $102.5M | ||
| Q4 24 | $112.2M | $127.9M | ||
| Q3 24 | $162.7M | $248.5M | ||
| Q2 24 | $75.4M | $308.6M | ||
| Q1 24 | $16.7M | $79.6M |
自由现金流率ATRRBA
| Q4 25 | 10.1% | 15.5% | ||
| Q3 25 | 11.9% | 17.3% | ||
| Q2 25 | 6.5% | 20.4% | ||
| Q1 25 | 2.9% | 9.2% | ||
| Q4 24 | 13.2% | 11.2% | ||
| Q3 24 | 17.9% | 25.3% | ||
| Q2 24 | 8.3% | 28.2% | ||
| Q1 24 | 1.8% | 7.5% |
资本支出强度ATRRBA
| Q4 25 | 9.0% | 5.7% | ||
| Q3 25 | 6.6% | 4.7% | ||
| Q2 25 | 6.6% | 7.2% | ||
| Q1 25 | 6.4% | 4.9% | ||
| Q4 24 | 7.8% | 5.0% | ||
| Q3 24 | 7.3% | 3.8% | ||
| Q2 24 | 7.5% | 2.6% | ||
| Q1 24 | 8.3% | 4.2% |
现金转化率ATRRBA
| Q4 25 | 2.47× | 2.33× | ||
| Q3 25 | 1.39× | 2.51× | ||
| Q2 25 | 1.13× | 2.97× | ||
| Q1 25 | 1.05× | 1.38× | ||
| Q4 24 | 1.77× | 1.56× | ||
| Q3 24 | 2.29× | 3.75× | ||
| Q2 24 | 1.59× | 3.04× | ||
| Q1 24 | 1.11× | 1.16× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ATR
| Pharma Segment | $833.1M | 87% |
| Other | $129.6M | 13% |
RBA
| Buyer Revenue | $577.2M | 48% |
| Seller Revenue | $255.2M | 21% |
| CA | $199.0M | 17% |
| Other | $124.7M | 10% |
| AU | $47.3M | 4% |
